Hsiang-Ming (Anthony) Wang, PhD, MBA, SM(NRCM)

Biosafety Officer, Select Agent Alternate Responsible Official

Anthony received his PhD in Cell and Molecular Biology from the University of Vermont and completed two years of post-doctoral research at the Ohio State University. His research focused on environmental and drug induced signal transduction pathways, mainly the MAPK/PI3K pathways, in mammalian models. Molecular biology tools such as protein purification, siRNA inhibition, site-directed mutagenesis, and introduction of dominant negative constructs were used in his studies to delineate the complicated signals involving either ultraviolet light or cholesterol homeostasis. Prior to his graduate study, Anthony spent one year in the transgenic facility at the National Taiwan University (NTU) performing pronuclear injection and husbandry of both transgenic and knockout mice after receiving a Bachelor degree in Medical Technology at NTU.

In 2007, Anthony was recruited by Center for Microbial Interface Biology (CMIB) at the Ohio State University as the BSL3 Core facility Operations Manager. He oversaw the commission, certification, and validation of several BSL3/ABSL3/Select Agent BSL3 facilities and supervised the daily operation of the BSL3 facilities. He is also responsible for training all researchers on BSL3 practices. Anthony was promoted as Research Administrator for CMIB and the Department of Microbial Infection and Immunity in 2011 and appointed as a voting member at the Institutional Biosafety Committee (IBC).

Anthony joined the University of Chicago, Office of Biological Safety in May of 2014 as the Assistant Biosafety Officer. He is an active member of the American Society for Microbiology (ASM) and received certifications with the ASM National Registry of Certified Microbiologists (NRCM) as a Specialist Microbiologist SM(NRCM) in 2013. He also holds a Master of Business Administration (MBA) degree from the Ohio State University Fisher College of Business.